Literature DB >> 12963789

Contraction-mediated glycogenolysis in mouse skeletal muscle lacking creatine kinase: the role of phosphorylase b activation.

Abram Katz1, Daniel C Andersson, Josephine Yu, Barbara Norman, Marie E Sandstrom, Be Wieringa, Hakan Westerblad.   

Abstract

Skeletal muscle that is deficient in creatine kinase (CK-/-) exhibits accelerated glycogenolysis during contraction. Understanding this phenomenon could provide insight into the control of glycogenolysis during contraction. Therefore, glycogen breakdown was investigated in isolated extensor digitorum longus CK-/- muscle. Muscles were stimulated to produce repeated tetani for 20 s in the presence of sodium cyanide to block mitochondrial respiration. Accumulation of lactate after stimulation was similar in wild-type (WT) and CK-/- muscles, whereas accumulation of glucose-6-phosphate was twofold higher in CK-/- muscles, indicating greater glycogenolysis in CK-/- muscles. Total phosphorylase activity was decreased by almost 30 % in CK-/- muscle (P < 0.001). Phosphorylase fractional activity (-/+ 3.3 mM AMP) was similar in both groups in the basal state (about 10 %), but increased to a smaller extent in CK-/- muscles after stimulation (39 +/- 4 % vs. 52 +/- 4 % in WT, P < 0.05). Inorganic phosphate, the substrate for phosphorylase, increased marginally in CK-/- muscles after stimulation (basal = 25.3 +/- 2.2 micromol (g dry muscle)-1; stimulated = 33.9 +/- 2.3 micromol (g dry muscle)-1), but substantially in WT muscles (basal = 11.4 +/- 0.7 micromol (g dry muscle)-1; stimulated = 54.2 +/- 4.5 micromol (g dry muscle)-1). Kinetic studies of phosphorylase b (dephosphorylated enzyme) from muscle extracts in vitro demonstrated higher relative activities in CK-/- muscles (60-135 %) in response to low AMP concentrations (up to 50 microM) in both the basal state and after stimulation (P < 0.05), whereas no differences in activity between CK-/- and WT muscles were observed at high AMP concentrations (> 100 microM). These data indicate that allosteric activation of phosphorylase b accounts for the accelerated glycogenolysis in CK-/- muscle during contraction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12963789      PMCID: PMC2343558          DOI: 10.1113/jphysiol.2003.051078

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  51 in total

Review 1.  Glycogen phosphorylase as a molecular target for type 2 diabetes therapy.

Authors:  Nikos G Oikonomakos
Journal:  Curr Protein Pept Sci       Date:  2002-12       Impact factor: 3.272

2.  Phosphocreatine kinetics at the onset of contractions in skeletal muscle of MM creatine kinase knockout mice.

Authors:  Brian B Roman; Ronald A Meyer; Robert W Wiseman
Journal:  Am J Physiol Cell Physiol       Date:  2002-12       Impact factor: 4.249

3.  Mitochondrial function in intact skeletal muscle fibres of creatine kinase deficient mice.

Authors:  Joseph D Bruton; Anders J Dahlstedt; Fabio Abbate; Hakan Westerblad
Journal:  J Physiol       Date:  2003-10-15       Impact factor: 5.182

4.  GLYCOGENOLYSIS DURING TETANIC CONTRACTION OF ISOLATED MOUSE MUSCLES IN THE PRESENCE AND ABSENCE OF PHOSPHORYLASE A.

Authors:  W H DANFORTH; J B LYON
Journal:  J Biol Chem       Date:  1964-12       Impact factor: 5.157

5.  A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose.

Authors:  J A Thomas; K K Schlender; J Larner
Journal:  Anal Biochem       Date:  1968-10-24       Impact factor: 3.365

6.  In vivo regulation of rat muscle glycogen synthetase activity.

Authors:  R Piras; R Staneloni
Journal:  Biochemistry       Date:  1969-05       Impact factor: 3.162

7.  Glucose 1,6-diphosphate formation by phosphoglucomutase in mammalian tissues.

Authors:  J V Passonneau; O H Lowry; D W Schulz; J G Brown
Journal:  J Biol Chem       Date:  1969-02-10       Impact factor: 5.157

Review 8.  Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus.

Authors:  J L Treadway; P Mendys; D J Hoover
Journal:  Expert Opin Investig Drugs       Date:  2001-03       Impact factor: 6.206

9.  Role of myoplasmic phosphate in contractile function of skeletal muscle: studies on creatine kinase-deficient mice.

Authors:  A J Dahlstedt; A Katz; H Westerblad
Journal:  J Physiol       Date:  2001-06-01       Impact factor: 5.182

10.  Phosphotransfer dynamics in skeletal muscle from creatine kinase gene-deleted mice.

Authors:  Petras P Dzeja; Andre Terzic; Bé Wieringa
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

View more
  9 in total

1.  Elongated mitochondrial constrictions and fission in muscle fatigue.

Authors:  Manuela Lavorato; Emanuele Loro; Valentina Debattisti; Tejvir S Khurana; Clara Franzini-Armstrong
Journal:  J Cell Sci       Date:  2018-12-05       Impact factor: 5.285

Review 2.  Regulation of glycogen breakdown and its consequences for skeletal muscle function after training.

Authors:  Abram Katz; Håkan Westerblad
Journal:  Mamm Genome       Date:  2014-04-29       Impact factor: 2.957

3.  Rearrangement of energetic and substrate utilization networks compensate for chronic myocardial creatine kinase deficiency.

Authors:  Petras P Dzeja; Kirsten Hoyer; Rong Tian; Song Zhang; Emirhan Nemutlu; Matthias Spindler; Joanne S Ingwall
Journal:  J Physiol       Date:  2011-08-30       Impact factor: 5.182

4.  Chemical and metabolomic screens identify novel biomarkers and antidotes for cyanide exposure.

Authors:  Anjali K Nath; Lee D Roberts; Yan Liu; Sari B Mahon; Sonia Kim; Justine H Ryu; Andreas Werdich; James L Januzzi; Gerry R Boss; Gary A Rockwood; Calum A MacRae; Matthew Brenner; Robert E Gerszten; Randall T Peterson
Journal:  FASEB J       Date:  2013-01-23       Impact factor: 5.191

5.  Raptor ablation in skeletal muscle decreases Cav1.1 expression and affects the function of the excitation-contraction coupling supramolecular complex.

Authors:  Rubén J Lopez; Barbara Mosca; Susan Treves; Marcin Maj; Leda Bergamelli; Juan C Calderon; C Florian Bentzinger; Klaas Romanino; Michael N Hall; Markus A Rüegg; Osvaldo Delbono; Carlo Caputo; Francesco Zorzato
Journal:  Biochem J       Date:  2015-02-15       Impact factor: 3.857

6.  Isoproterenol enhances force production in mouse glycolytic and oxidative muscle via separate mechanisms.

Authors:  Sarah J Blackwood; Abram Katz
Journal:  Pflugers Arch       Date:  2019-08-21       Impact factor: 3.657

Review 7.  A century of exercise physiology: key concepts in regulation of glycogen metabolism in skeletal muscle.

Authors:  Abram Katz
Journal:  Eur J Appl Physiol       Date:  2022-03-30       Impact factor: 3.346

8.  Defects in Galactose Metabolism and Glycoconjugate Biosynthesis in a UDP-Glucose Pyrophosphorylase-Deficient Cell Line Are Reversed by Adding Galactose to the Growth Medium.

Authors:  Christelle Durrant; Jana I Fuehring; Alexandra Willemetz; Dominique Chrétien; Giusy Sala; Riccardo Ghidoni; Abram Katz; Agnès Rötig; Monica Thelestam; Myriam Ermonval; Stuart E H Moore
Journal:  Int J Mol Sci       Date:  2020-03-16       Impact factor: 5.923

Review 9.  Skeletal Muscle in ALS: An Unappreciated Therapeutic Opportunity?

Authors:  Silvia Scaricamazza; Illari Salvatori; Alberto Ferri; Cristiana Valle
Journal:  Cells       Date:  2021-03-02       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.